CLORPACTIN™ WCS-90
Broad spectrum topical antimicrobial and bowel cleanser

Clorpactin WCS-90 is a stabilized organic derivative of hypochlorous acid. It is a white, water soluble powder. It has high antimicrobial activity that is markedly cidal rather than inhibitory. In concentrations ranging from 0.2-0.5%, its solutions destroy microorganisms by oxidation and hypochlorination, regardless of their type or resistance to other agents. Exposing microbes to a solution of Clorpactin WCS-90 results in microbial lysing and destruction. There have been no reported cases of adverse effects on healthy tissue despite this powerful activity.

Clorpactin WCS-90 has many medical uses, including cleansing of the bowel prior to colon resection.1 Intraoperative colonic irrigation with an antiseptic has been shown to be an effective method of wound sepsis prevention.2 Clorpactin WCS-90 has been shown to be an effective intestinal antiseptic.3, 4, 5 Its solutions exhibit pronounced wetting properties, which assist in dissolving stool, and liberate hypochlorous acid in vapor form, which is lethal to microorganisms even beyond the reach of the solution. Its broad antimicrobial spectrum, lack of allergenicity, clean pleasant odor, lubricating texture, clear transparent color, and lack of toxicity to healthy mucosa, make it an excellent choice for irrigation during routine colon and anorectal surgery.

Clinical and experimental studies provide evidence that perioperative implantation of viable shed cancer cells is a cause for local cancer recurrence. 6, 7, 8, 9, 10, 11, 12 Hypochlorite solutions have been shown to be effective tumoricidal agents. 3, 13, 14 In experimental models, irrigations of the colon lumen with sodium hypochlorite and other tumoricidal agents prior to anastomosis produced significant decreases in cancer cell implantation rates. 15, 16, 17 In order to prevent local cancer recurrence, rectal irrigation with and without tumoricidal agents has been widely practiced, 18, 19 although the efficacy of this procedure remains unproven. 20 Clorpactin and other hypochlorite solutions are among the tumoricidal agents that have been used clinically for this purpose. 21, 22

When used as recommended, Clorpactin WCS-90 is safe and well-tolerated. Many millions of liters of solution have been used since 1955 with no reports of toxicity or allergic reaction, despite the variety of conditions treated and methods of application.

Based on many years of clinical use and data from numerous clinical and experimental studies, Clorpactin WCS-90 has been shown to have numerous advantages as a topical chemotherapeutic agent:

  • Active against a broad spectrum of microorganisms, including Gram-negative and Gram-positive bacteria, fungi, yeast, mold, viruses and spores, when employed topically in the recommended concentrations.
  • Tumoricidal activity.
  • No adverse effect on normal tissue or epithelial growth at these same concentrations.
  • No evidence of the development of resistant organisms.
  • No systemic toxicity, as long as the recommended concentrations are not exceeded.
  • No reported cases of the development of intolerance or allergic sensitivity.

DIRECTIONS FOR USE: Add one bottle of powder (2 grams) for every 500 mL of lukewarm sterile water or saline to achieve a 0.4% solution. Stir or shake for several minutes. Irrigate the bowel with this solution using a syringe or an IRRIGUT® intestinal irrigator.

Clorpactin WCS-90 is slow to dissolve in water. The organic hypochlorous acid complex is carried by an anhydrous hexametaphosphate base, which requires time to rehydrate. However, the initial reaction with water releases the hypochlorous acid within 2 to 3 minutes of stirring. This is the active agent. The light, fluffy residue is actually the slowly rehydrating phosphates, which have no pharmacological value. This residue is harmless physiologically if incompletely dissolved.

CAUTION: Clorpactin WCS-90 should never be used as a powder. The strong oxidizing power of the powder will cause burns that can result in necrotic tissue. It should be used as a solution only, and in the concentrations specified. Not for systemic use.

NOTE: The statements contained herein are based on data from various clinical and experimental studies that have been conducted over the past 50 years, and have not been evaluated by the FDA. For this reason, uses of Clorpactin WCS-90 that are suggested herein are not listed by the manufacturer as recommended or approved uses.

  • Catalog No. WCS-90
  • Five 2-gram bottles per box (10 grams net wt. per box)
  • 12 boxes per carton
  • Store under refrigeration
References:
  1. Gliedman, ML, Grant RN, Vestal BL, Karlson KE. Impromptu bowel cleansing and sterilization. Surgery 1958;43(2):282-287
  2. Banich FE, Mendak SJ Jr. Intraoperative colonic irrigation with povidone iodine: an effective method of wound sepsis prevention. 1989;32:219-222
  3. Gliedman ML, Grant RN, Vestal BL, Rogers CE, Karlson KE. Clorpactin, a surgical adjunct; antimicrobial and tumorcidal action. Surgical Forum 1957;8:104-8
  4. Leiboff AR, Crowley M, Spano L, Zito G, Dennis C. Intraoperative high-flow antegrade irrigation: a new bowel-cleansing system. Dis Colon Rectum 1985;28:323-332
  5. Scammell BE, Phillips RP, Brown R, Burdon DW, Keighley MRB. Influence of rectal washout on bacterial counts in the rectal stump. Br J Surg 1985;72:548-550
  6. McGrew EA, Laws JF, Cole WH. Free malignant cells in relation to recurrence of carcinoma of colon. JAMA 1954;154:1251-4
  7. Rygick AN, Fain SN, Pestovskaja GN. Viability of cancer cells penetrating tissues during operation for cancer of the rectum. Dis Colon Rectum 1969;12:351-6
  8. Skipper D, Cooper AJ, Marson JE, Taylor I. Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987;74:1049-1052
  9. Umpleby HC, Fermor B, Symes MO, Williamson RC. Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984;71:659-663
  10. Long TL, Edwards RH. Implantation Metastasis as a Cause of Local Recurrence of Colorectal Carcinoma. Am J Surg 1989;157:194-200
  11. Gertsch P, Baer HU, Kraft R, Maddern GJ, Altermatt HJ. Malignant cells are collected on circular staplers. Dis Colon Rectum 1992;35:238-41
  12. Kluger Y, Galili Y, Yossiphov J, Shnaper A, Goldman G, Rabau M. Model of implantation of tumor cells simulating recurrence in colonic anastomosis in mice. Dis Colon Rectum 1998;41:1506-1510
  13. Ketcham AS. Cancer 1960;13(1):20-24
  14. McDonald GO, Gines SM, Cole WH. Wound irrigation in cancer surgery. Arch Surg 1960;80:920
  15. Hubens G, Williams G. Factors influencing the implantation of colon cancer cells on the colonic suture line in rats. Eur Surg Res. 1990;22(6):356-64
  16. Basha G, Penninckx F, Mebis J, Geboes K, Yap P. Prevention of anastomotic tumour take by on-table colon washout with povidone-iodine: an experimental study in rats. Eur Surg Res 1999;31(2):202-9
  17. Tsunoda A, Shibusawa M, Tsunoda Y, Kamiyama G, Yamazaki K, Kusano M. Effect of Povidone-Iodine on Anastomotic Tumor Growth in an Experimental Model of Colorectal Cancer Surgery. Anticancer Research 1999; 19:1149-1152
  18. Docherty JG, McGregor JR, Purdie CA, Galloway DJ, O’Dwyer PJ. Efficacy of tumoricidal agents in vitro and in vivo. Br J Surg 1995;82:1050-1052
  19. Hool GR, Church JM, Fazio VW. Decision-Making in Rectal Cancer Surgery. Dis Colon Rectum 1998;41:147-152
  20. Byrne CM, Perer DS, King DW. Does rectal washout during anterior resection prevent local tumor recurrence? Dis Colon Rectum 2005;48:172-173
  21. Labow SB, Salvati EP, Rubin RJ. Suture line recurrence in carcinoma of colon and rectum. Dis Colon Rectum 1975;18:123-125
  22. Hubens G, Willems G. Efficacy of tumorcidal agents in vitro and in vivo. Br J Surg 1996;83(1):132-133

 

  Legal Notice Privacy Policy